The aim of the present systematic review is to examine the role of fluorodeoxyglucose (FDG)
positron emission tomography (PET) associated with computed tomography (CT) or …

Pancreatic ductal adenocarcinoma represents 90% of all pancreatic tumors. The only hope
for prolonged survival in patients with this condition still remains surgery with complete R0 …

Abstract Background The Response Evaluation Criteria in Solid Tumors (RECIST) for
computed tomography (CT) is preoperatively used to evaluate therapeutic effects. However …

Despite combination chemotherapy demonstrating a positive effect on survival, the clinical
outcomes of pancreatic adenocarcinoma (PDAC) remain poor. Radiotherapy was previously …

Methods We conducted an extensive review, including relevant articles dealing with
traditional imaging, functional imaging and minimally invasive surgical procedures before …

Backgrounds/Aims We performed a retrospective, single-center cohort study to evaluate the
impact of various treatment modalities and recent changes in treatment modalities, including …

18 F-FDG-PET is complementary to conventional imaging in patients with clinical suspicion
for exocrine pancreatic malignancies. It has similar if not superior sensitivity and specificity …

This work evaluated the use of the positron emission tomography (PET)/computed
tomography (CT) technique to assess the early therapeutic response and predict the …

Neoadjuvant therapy (NAT) has been widely recommended for managing patients with
borderline resectable pancreatic cancer and resectable tumors with high risk factors …

Rationale and Objective To assess the possibility of differentiating pulmonary carcinoids
from hamartomas and typical from atypical carcinoids by means of 18 F-FDG PET/CT …